Mounjaro tirzepatide injection pen
Mounjaro®
for type 2 diabetes, and what it means for weight
Tirzepatide
GIP and GLP-1
Weekly injection

Mounjaro (tirzepatide) is a once-weekly injection approved for type 2 diabetes. It is not approved for weight loss. If weight is your main goal, Zepbound, which also contains tirzepatide, is approved for weight management, and your physician can help you find the right fit.

  • Approved for type 2 diabetes
  • Works on two hormones
  • Insurance checked first

Coverage checked before your visit

Mounjaro is approved for type 2 diabetes, and coverage depends on your plan. We check it before your first visit and handle the prior authorization if your plan needs one. If you want help with weight and do not have type 2 diabetes, ask us about Zepbound, Wegovy, the Wegovy pill or Foundayo.

Book my consultation

Reviewed by Darshan Patel, MD, obesity medicine physician. Last reviewed November 13, 2026.

mounjaro® (tirzepatide)

Everything you need to

know about Mounjaro®

Weekly injection pens

What is Mounjaro and who is it for?

Mounjaro (tirzepatide) is a prescription medicine made by Eli Lilly for type 2 diabetes. It is FDA-approved to:

Improve blood sugar: with diet and exercise, in adults and children 10 and older with type 2 diabetes.

Protect the heart: reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for them.

A person holding an injection pen

Mounjaro or Zepbound?

Mounjaro and Zepbound both contain tirzepatide, and both come in weekly doses from 2.5 mg to 15 mg.

Mounjaro is approved for type 2 diabetes.

Zepbound is approved for weight management in adults with obesity, or overweight and a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.

Your insurance plan decides coverage for each one by its own rules. We sort that out before your first visit. Read about Zepbound.

A once-weekly injection under the skin of the stomach area

How Mounjaro works

Tirzepatide acts like two hormones your gut releases after you eat, GIP and GLP-1.

Steadies blood sugar: it helps your body release insulin when blood sugar rises.

Quiets hunger: it signals your brain that you have had enough.

Keeps you full longer: food leaves your stomach more slowly.

Taking it safely

Mounjaro is a once-weekly injection under the skin, at any time of day, with or without food. Your physician starts at 2.5 mg and raises the dose step by step, and your care team shows you how to inject.

Most side effects are stomach-related and ease as your body adjusts. Mounjaro is not right for everyone, so your physician goes through your health history with you first. The details from the FDA label are below.

Dosing steps

  • The label starts at 2.5 mg once a week.
  • After at least 4 weeks on a dose, it can go up by 2.5 mg if more blood sugar control is needed.
  • The highest dose is 15 mg a week for adults and 10 mg a week for children 10 and older.

Common side effects

  • The most common side effects are nausea, diarrhea, less appetite, vomiting, constipation, indigestion and stomach pain.
  • They are most likely when you start or raise the dose, and they often ease as your body adjusts.

Boxed warning

  • In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid cancer, in people.
  • Tell your physician right away about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.

Who should not take it

  • Tirzepatide is not for you if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).
  • It is also not for anyone who has had a serious allergic reaction to tirzepatide or to anything in the medicine.
  • If you are pregnant or planning a pregnancy, tell your physician.

Less common but serious

  • Problems listed on the label include inflammation of the pancreas, low blood sugar with insulin or a sulfonylurea, serious allergic reactions, kidney problems from losing fluid, severe stomach problems, eye changes in people with diabetic eye disease and gallbladder problems.
  • Never share a Mounjaro KwikPen with anyone, even if the needle is changed.
  • Tell your care team before any surgery or sedation: GLP-1 medicines can raise the risk of food getting into the lungs during anesthesia.

What Mounjaro costs

With insurance: coverage depends on your plan. We check it before your first visit, submit any prior authorization for you and handle appeals if needed. Read how to check your GLP-1 coverage.

Copay help: we help you use the maker's copay assistance if you have commercial insurance.

Your visits: Most major insurance accepted, plus convenient cash pay options. Visits are billed to your insurance, and you pay any copay.

Medicare: we bill Medicare for visits.

Aayu Well's own self-pay plans are for compounded semaglutide and compounded tirzepatide. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. They are not the same as Mounjaro or any brand-name medicine. Read about tirzepatide options.

How Aayu Well helps

Insurance checked first: we look at your coverage before your first visit, so you know your options before you decide.

Prior authorization handled: our team prepares and submits it for brand-name medicine as a concierge service, and handles appeals if your plan says no.

Copay help: if you have commercial insurance, we help you use the maker's copay assistance.

A physician who knows you: Darshan Patel, MD, an obesity medicine physician, sees you by video or in person in Deer Park, Illinois, and adjusts your dose with you.

A registered dietitian: help with meals that fit your new appetite, protein on a GLP-1 and keeping your muscle.

A care team between visits: message us about side effects, doses or refills, and hear back from people who know your plan.

A plan for the long run: Do I have to take a GLP-1 forever?

We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin.

About Aayu Well

Aayu Well is a physician-led healthcare practice. Darshan Patel, MD, an obesity medicine physician, sees patients by video and in person at our clinic in Deer Park, Illinois, together with a registered dietitian and a care team.

We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin. Most major insurance accepted, plus convenient cash pay options. We check your coverage before your first visit and handle prior authorization for brand-name medicine, including appeals.

A GLP-1 medicine works best with a plan around it: food that fits your life, strength work that protects your muscle, and a physician who adjusts your dose with you. That is the care we give.

Other medicines your physician may consider

Every body is different. Depending on your health history, your insurance and your goals, your Aayu Well physician may recommend a different medicine. Some are approved for weight management and others for type 2 diabetes.

Wegovy

semaglutide injection

Wegovy
Learn More
Wegovy pill

semaglutide tablets

Wegovy pill
Learn More
Zepbound

tirzepatide injection

Zepbound
Learn More
Foundayo

orforglipron tablets

Foundayo
Learn More
Semaglutide

brand-name or compounded

Semaglutide
Learn More
Tirzepatide

brand-name or compounded

Tirzepatide
Learn More
Ozempic

semaglutide injection

Ozempic
Learn More
Saxenda

liraglutide injection

Saxenda
Learn More
Rybelsus

semaglutide tablets

Rybelsus
Learn More
Trulicity

dulaglutide injection

Trulicity
Learn More
Victoza

liraglutide injection

Victoza
Learn More